Maho Takuwa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maho Takuwa has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Hirokazu Shoji
Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
1 shared publication - Toshihiro Haga
Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan
1 shared publication - Yukinori Yamagata
Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 11 September 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (10) , 4320-4324
Non-ampullary duodenal mixed neuroendocrine–non-neuroendocrine neoplasm initially diagnosed as adenocarcinoma: a case report
Introduction: Mixed neuroendocrine–non-neuroendocrine neoplasms (MiNENs) are rare tumors composed of neuroendocrine and non-neuroendocrine components. Their occurrence in the duodenum is extremely uncommon. Preoperative diagnosis is difficult because the neuroendocrine component may not be detected in biopsy specimens. We report a rare case of non-ampullary duodenal MiNEN initially diagnosed as adenocarcinoma. Case presentation: A 56-year-old man was found to have a tumor in the duodenal bulb during routine endoscopic examination. Biopsy revealed moderately to poorly differentiated adenocarcinoma, and computed tomography demonstrated bulky regional lymph node metastasis without distant disease. Neoadjuvant chemotherapy with S-1 plus oxaliplatin was administered based on treatment strategies used for advanced gastric cancer in Japan. Post-treatment evaluation showed stable disease, and pancreaticoduodenectomy with regional lymph node dissection achieved R0 resection. Histopathological examination revealed both adenocarcinoma and neuroendocrine carcinoma (NEC) components, leading to a diagnosis of MiNEN. Lymph node metastases demonstrated component-specific heterogeneity, with NEC involvement in station No. 8a and adenocarcinoma in the remaining metastatic nodes. Postoperative platinum-based chemotherapy was administered, and the patient remains recurrence-free at 16 months after surgery. Discussion: Duodenal MiNEN presents diagnostic and therapeutic challenges because biopsy specimens may fail to detect the neuroendocrine component preoperatively. In the present case, component-specific lymph node metastases suggested biological heterogeneity and may have influenced treatment selection. Conclusion: Non-ampullary duodenal MiNEN is a rare and diagnostically challenging disease. This case highlights the importance of accurate pathological evaluation and multidisciplinary management.
- 11 September 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (10) , 4320-4324
Open AccessNon-ampullary duodenal mixed neuroendocrine–non-neuroendocrine neoplasm initially diagnosed as adenocarcinoma: a case report
Introduction: Mixed neuroendocrine–non-neuroendocrine neoplasms (MiNENs) are rare tumors composed of neuroendocrine and non-neuroendocrine components. Their occurrence in the duodenum is extremely uncommon. Preoperative diagnosis is difficult because the neuroendocrine component may not be detected in biopsy specimens. We report a rare case of non-ampullary duodenal MiNEN initially diagnosed as adenocarcinoma. Case presentation: A 56-year-old man was found to have a tumor in the duodenal bulb during routine endoscopic examination. Biopsy revealed moderately to poorly differentiated adenocarcinoma, and computed tomography demonstrated bulky regional lymph node metastasis without distant disease. Neoadjuvant chemotherapy with S-1 plus oxaliplatin was administered based on treatment strategies used for advanced gastric cancer in Japan. Post-treatment evaluation showed stable disease, and pancreaticoduodenectomy with regional lymph node dissection achieved R0 resection. Histopathological examination revealed both adenocarcinoma and neuroendocrine carcinoma (NEC) components, leading to a diagnosis of MiNEN. Lymph node metastases demonstrated component-specific heterogeneity, with NEC involvement in station No. 8a and adenocarcinoma in the remaining metastatic nodes. Postoperative platinum-based chemotherapy was administered, and the patient remains recurrence-free at 16 months after surgery. Discussion: Duodenal MiNEN presents diagnostic and therapeutic challenges because biopsy specimens may fail to detect the neuroendocrine component preoperatively. In the present case, component-specific lymph node metastases suggested biological heterogeneity and may have influenced treatment selection. Conclusion: Non-ampullary duodenal MiNEN is a rare and diagnostically challenging disease. This case highlights the importance of accurate pathological evaluation and multidisciplinary management.